Bionano Genomics, Inc. (BNGO) Institutional Ownership

Ownership Summary

Bionano Genomics, Inc. (NASDAQ:BNGO) currently has 21 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• The percentage of Bionano Genomics owned by institutions changed from 4.6% in September 2025 to 14.1% in December 2025, marking a slight up trend.
• In percentage terms, this reflects as a holdings change of 369.84% quarter on quarter, and a decrease of 60.38% year over year.
• The latest 13F cycle for Bionano Genomics reveals that of 21 total investors, 7 funds grew their exposure, whereas 6 reduced theirs and 8 made no changes.
• This class of investors increased its holdings in Bionano Genomics to 752.08K shares for the 13F-cycle ending December 2025, up by 592.01K shares quarter on quarter, and down 5.36Mn shares year over year.
• GSA CAPITAL PARTNERS LLP's holding of 337.78K shares as of December 31, 2025 makes it the primary institutional investor in Bionano Genomics, owning 6.32% of the stock.
• Among the most significant buyers of Bionano Genomics during December 2025 were GSA CAPITAL PARTNERS LLP (337.78K), DRW Securities, LLC (168.45K), GEODE CAPITAL MANAGEMENT, LLC (39.93K), RENAISSANCE TECHNOLOGIES LLC (37.00K), VANGUARD GROUP INC (31.85K).
• Leading sellers of Bionano Genomics stock in December 2025 included UBS Group AG (54.82K), MORGAN STANLEY (3.98K), WELLS FARGO & COMPANY/MN (83), GROUP ONE TRADING LLC (46), SBI Securities Co., Ltd. (10).
• The top 10 institutional holders of Bionano Genomics for the quarter ending December 2025 included GSA CAPITAL PARTNERS LLP (337.78K), DRW Securities, LLC (168.45K), VANGUARD GROUP INC (82.31K), GEODE CAPITAL MANAGEMENT, LLC (66.77K), RENAISSANCE TECHNOLOGIES LLC (37.00K), JANE STREET GROUP, LLC (22.17K), R Squared Ltd (13.77K), BlackRock, Inc. (9.94K), UBS Group AG (9.06K), MORGAN STANLEY (2.22K).